Q2
LONG ANSWER
10M
★ High-yield
Classify streptococci. Describe the virulence factors, diseases and non-suppurative sequelae of Streptococcus pyogenes.
Classification of Streptococci
- Gram-positive cocci in chains or pairs, non-motile, non-sporing, catalase negative
| Basis | Groups |
|---|---|
| By haemolysis on blood agar | Alpha — partial, greenish (S. Pneumoniae, viridans group); beta — complete, clear (S. Pyogenes, S. Agalactiae); gamma — none (enterococci, S. Bovis) |
| By lancefield grouping | Based on the cell wall C carbohydrate antigen; groups A to H and K to V. Group A = S. Pyogenes; group B = S. Agalactiae (neonatal sepsis and meningitis); group D = enterococci and S. Bovis |
| By biochemical reactions | S. Pyogenes is bacitracin sensitive and PYR positive; S. Agalactiae is bacitracin resistant and camp test positive; pneumococcus is optochin sensitive and bile soluble |
| Non-groupable | Viridans streptococci (S. Mitis, S. Sanguinis, S. Mutans) — oral commensals causing subacute endocarditis and dental caries |
Virulence Factors of Streptococcus Pyogenes
| Factor | Action |
|---|---|
| M protein — the major virulence factor | Antiphagocytic, and the basis of type-specific immunity. Over 100 M types exist, so infection with one gives no protection against the others — which is why repeated attacks occur and why vaccine development is difficult. Certain types are rheumatogenic and others nephritogenic |
| Capsule (hyaluronic acid) | Antiphagocytic, and non-antigenic because it is identical to host hyaluronic acid — molecular disguise |
| Streptolysin O | Oxygen-labile and strongly antigenic — the basis of the antistreptolysin O (ASO) titre. Cardiotoxic |
| Streptolysin S | Oxygen-stable and non-antigenic; responsible for the beta-haemolysis seen on the plate |
| Pyrogenic (erythrogenic) exotoxins | Superantigens, phage-encoded; cause the rash of scarlet fever and streptococcal toxic shock syndrome |
| Spreading enzymes | Streptokinase (fibrinolysin — dissolves the fibrin barrier, so infection spreads rather than localising), hyaluronidase, DNase B, C5a peptidase |
| Lipoteichoic acid and F protein | Adhesion to epithelium |
Diseases
- Suppurative (invasive) — pharyngitis and tonsillitis (the commonest); impetigo and pyoderma; erysipelas (a sharply demarcated superficial cellulitis) and cellulitis; necrotising fasciitis; puerperal sepsis; lymphangitis; otitis media and sinusitis; and bacteraemia
- Toxin-mediated — scarlet fever (a punctate erythematous rash sparing the perioral area, with a strawberry tongue and later desquamation) and streptococcal toxic shock syndrome
- Non-suppurative sequelae — the immunologically mediated complications, which are the reason streptococcal sore throat is treated at all
| Feature | Acute rheumatic fever | Acute post-streptococcal glomerulonephritis |
|---|---|---|
| Preceding infection | Throat only — never skin | Throat or skin (pyoderma) |
| Latent period | 2 to 3 weeks | 1 to 2 weeks after throat; 3 to 6 weeks after skin |
| M types | Rheumatogenic — 1, 3, 5, 6, 18 | Nephritogenic — 12 (throat), 49 (skin) |
| Mechanism | Molecular mimicry — antibody to M protein cross-reacts with cardiac myosin and sarcolemma (type II) | Immune complex deposition in the glomerulus (type III) |
| Features | Carditis, migratory polyarthritis, chorea, erythema marginatum, subcutaneous nodules (Jones criteria) | Haematuria, oedema, hypertension, low C3 |
| Recurrence | Yes — each attack worsens valve damage, hence lifelong prophylaxis | Rare; prophylaxis is not indicated |
| Prognosis | Chronic rheumatic heart disease | Usually complete recovery in children |
CLINICAL PEARL
Treating a streptococcal sore throat does not shorten it much; it prevents rheumatic fever. The pharyngitis settles in a few days with or without penicillin. What antibiotic treatment achieves is eradication of the organism before the immune response that cross-reacts with heart valves develops — and it works if given within about nine days. In India, where rheumatic heart disease remains a major cause of cardiac death in the young, that is the whole justification for treating a self-limiting illness.
Laboratory Diagnosis
- Throat swab — Gram stain is of little value (the throat carries many organisms); culture on blood agar shows small beta-haemolytic colonies
- Identification — catalase negative; bacitracin sensitivity and PYR positive; Lancefield grouping by latex agglutination
- Rapid antigen detection tests are specific but less sensitive, so a negative result in a child is confirmed by culture
- Serology for the non-suppurative sequelae, where the organism has usually gone by the time the illness appears — ASO titre rises after throat infection, but poorly after skin infection because skin lipids inhibit streptolysin O; anti-DNase B is therefore the better test after pyoderma
- Streptozyme detects several antibodies together
Other Medically Important Streptococci
| Organism | Group | Clinical importance |
|---|---|---|
| S. Agalactiae | B | Colonises the vagina in up to 30% of women; the leading cause of neonatal sepsis and meningitis. Bacitracin resistant, camp test positive, hippurate hydrolysis positive. Prevented by antenatal screening and intrapartum penicillin |
| Viridans group (S. Mitis, sanguinis, mutans) | Non-groupable | Alpha-haemolytic oral commensals; the commonest cause of subacute bacterial endocarditis on damaged valves after dental procedures; S. Mutans causes dental caries. Optochin resistant and bile insoluble, which distinguishes them from pneumococcus |
| S. Bovis (S. Gallolyticus) | D | Endocarditis and bacteraemia with a strong association with colonic carcinoma — its isolation mandates colonoscopy |
| S. Anginosus (milleri) group | Variable | A marked tendency to form abscesses — brain, liver and lung |
| Peptostreptococcus | — | Anaerobic; part of polymicrobial abscesses and intra-abdominal sepsis |
Treatment and Applied Aspects
- Penicillin remains the drug of choice — remarkably, S. Pyogenes has never developed penicillin resistance after eighty years of use, which is almost unique among bacteria. Erythromycin or a macrolide in penicillin allergy
- Secondary prophylaxis after rheumatic fever — benzathine penicillin every 3 to 4 weeks, continued for years or for life depending on carditis; this prevents recurrent attacks and progressive valve damage, and is the single most important streptococcal intervention in India
- Add clindamycin in necrotising fasciitis and toxic shock — it inhibits toxin production and is unaffected by the high organism density that renders penicillin less effective
- Necrotising fasciitis is a surgical emergency; pain out of proportion to the visible signs is the early clue, and survival depends on early and radical debridement rather than on antibiotics
- Group B streptococcus screening in pregnancy and intrapartum penicillin prevent neonatal sepsis and meningitis
- Viridans streptococci cause subacute endocarditis after dental procedures; prophylaxis is now restricted to the highest-risk cardiac lesions, and good dental hygiene matters more than antibiotic cover
- Use a clinical score to decide who needs a throat swab; most sore throats are viral, and treating all of them wastes antibiotics while treating none permits rheumatic fever
- Ask specifically about a sore throat weeks earlier in a child with arthritis, chorea or heart failure; the infection is often forgotten by the time the sequel appears
- Isolation of S. Bovis from blood mandates colonoscopy, because of its strong association with colonic carcinoma — a microbiological result that directly triggers a surgical investigation
- Erysipelas and cellulitis differ in their margins; erysipelas is sharply demarcated and raised, involving the upper dermis and lymphatics, whereas cellulitis has an indistinct edge
- Penicillin sensitivity in S. Pyogenes has never been lost, so routine sensitivity testing is unnecessary for penicillin, though macrolide resistance does occur and matters in allergic patients
- Rheumatic fever is diagnosed by the JONES criteria with evidence of preceding streptococcal infection; the microbiology supports a clinical diagnosis rather than making one
- Anti-DNase B is the better serological test after skin infection, since skin lipids inhibit streptolysin O and the ASO titre may not rise at all
All questions in Gram-positive Cocci & Bacilli
- Q1Classify staphylococci. Describe the virulence factors, toxin-mediated diseases and laboratory diagnosis of Staphylococcus aureus. ★
- Q2Classify streptococci. Describe the virulence factors, diseases and non-suppurative sequelae of Streptococcus pyogenes. ★
- Q3Describe Corynebacterium diphtheriae with its morphology, toxin, clinical features, laboratory diagnosis and prevention. ★
- Q4Describe Clostridium tetani and Clostridium perfringens with their toxins, clinical features and management. ★
- Q5Describe Bacillus anthracis with its morphology, toxin, clinical forms and diagnosis. Add a note on other aerobic spore-bearers. ★
- SN1Describe Streptococcus pneumoniae with its identification, diseases and prevention. ★
- SN2Describe MRSA with its mechanism of resistance, detection, treatment and control. ★
- SN3Describe Clostridium botulinum and botulism with its clinical forms and management. ★
- SN4Describe Clostridioides difficile infection with its pathogenesis, diagnosis and management. ★
- SN5Describe the enterococci with their intrinsic resistance, infections and VRE. ★
- SN6Describe Listeria monocytogenes with its pathogenesis, clinical disease and treatment. ★
- SN7Compare Actinomyces and Nocardia. Add a note on mycetoma.